Related Experiment Video
Updated: Nov 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Inaugural Pharmacogenomics Access and Reimbursement Symposium
Sara L Rogers1, George P Patrinos2,3,4, Christina Mitropoulou5
1American Society of Pharmacovigilance, Houston, TX 77225, USA.
Abstract:
The Pharmacogenomics Access & Reimbursement Symposium, a landmark event presented by the Golden Helix Foundation and the Pharmacogenomics Access & Reimbursement Coalition, was a 1-day interactive meeting comprised of plenary keynotes from thought leaders across healthcare that focused on value-based strategies to improve patient access to personalized medicine. Stakeholders including patients, healthcare providers, industry, government agencies, payer organizations, health systems and health policy organizations convened to define opportunities to improve patient access to personalized medicine through best practices, successful reimbursement models, high quality economic evaluations and strategic alignment. Session topics included health technology assessment, health economics, health policy and value-based payment models and innovation.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Dosage Regimens: Partial Pharmacokinetic Parameters
Dosage Regimen: Individualization
Analysis of Population Pharmacokinetic Data
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

